Condition

Glaucoma, Primary Open Angle

ClinicalTrials.gov condition label

Clinical trials26

Recruiting2

Common interventions25

Lead sponsors shown15

Clinical trials

26 shown

Caffeine Consumption in Glaucoma Patients and Healthy SubjectsNCT03675412 · 2018-12-30

Adaptive Optics Retinal ImagingNCT05370287 · 2018-01-22

The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma PatientsNCT04007276 · 2026-11-10

NOT_YET_RECRUITING

Treating Psychosocial Distress in GlaucomaNCT06053307 · 2025-04-01

Safety and Feasibility of the ELIOS System in POAG PatientsNCT05999006 · 2023-10-18

Effect of Peripapillary Atrophy to Diagnose Glaucoma in High MyopiaNCT05964634 · 2023-08-01

Glaucoma Assessment Via Reading AbilityNCT05673954 · 2023-01-01

Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma PatientsNCT05181046 · 2021-11-06

Excimer Laser Trabeculostomy Glaucoma Treatment StudyNCT04899063 · 2021-05-10

The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTANCT05474716 · 2020-05-01

Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone InsertNCT04465864 · 2020-02-10

Safety and IOP-Lowering Effects of WB007NCT04149899 · 2019-11-14

UCP (Ultrasound Cyclo Plasty) in the Treatment of Chinese Patients With Primary Open-angle GlaucomaNCT04321122 · 2018-08-12

Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution)NCT04737928 · 2018-04-02

Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once DailyNCT03067415 · 2017-03-30

LSFG in Patients With Normal Tension Glaucoma Tension GlaucomaNCT03318510 · 2017-01-01

Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular HypertensionNCT02858284 · 2016-07-01

Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular HypertensionNCT02796560 · 2016-07-01

Longitudinal Study on Glaucoma Surgery Using XEN® Gel StentNCT03151577 · 2015-01-01

Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle GlaucomaNCT02679482 · 2014-09-01

A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical SettingNCT01999348 · 2013-11-25

A Study of Bimatoprost 0.01% in the Clinical SettingNCT01814761 · 2013-05-01

A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical ReasonsNCT01853085 · 2013-04-01

NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and NeuroenhancementNCT01408472 · 2011-04-01

Assessment of Effectiveness Ex-Press Surgery ModificationNCT03800589 · 2010-12-01

A Study of LUMIGAN® RC in the Clinical SettingNCT01833741 · 2009-12-01

Common interventions

Bimatoprost 0.01%DRUG2 ELIOS ProcedureDEVICE2 Acceptance commitment therapyBEHAVIORAL1 Adaptive optics imagingDEVICE1 Bimatoprost Ophthalmic SolutionDRUG1 Brand name travoprostDRUG1 Brimonidine tartrate 0.2% ophthalmic solutionDRUG1 brimonidine tartrate ophthalmic solution 0.025%DRUG1 C-Read testDIAGNOSTIC_TEST1 Caffeine tabletDIETARY_SUPPLEMENT1 D565(Latanoprost 50㎍/㎖)DRUG1 D565H(Latanoprost 25㎍/㎖)DRUG1 deep sclerectomy, phacoemulsification, ExPress implantationPROCEDURE1 Fixed Combination Bimatoprost and TimololDRUG1 Generic travoprostDRUG1 Intracanalicular Dexamethasone, 0.4 mg insertDRUG1 Laser Speckle FlowgraphyDEVICE1 LatanoprostDRUG1 Nanodropper adaptorDEVICE1 NT-501 CNTF ImplantDRUG1 OCT imagingDIAGNOSTIC_TEST1 Original eyedrop bottle/No NanodropperOTHER1 oxygen inhalationOTHER1 phacoemulsification with implantation of the Ex-PressPROCEDURE1 ShamDEVICE1

Leading sponsors

Allergan4 Elios Vision, Inc.2 Zhongshan Ophthalmic Center, Sun Yat-sen University2 Augenabteilung Allgemeines Krankenhaus Linz1 Bausch & Lomb Incorporated1 Chong Kun Dang Pharmaceutical1 Duke University1 EyeSonix1 Fayoum University1 Food and Drug Administration (FDA)1 Fundación Oftalmológica Nacional1 Jeffrey L Goldberg1 Military Institute od Medicine National Research Institute1 Nanodropper, Inc.1 Peking University1

Trial status mix

COMPLETED15

UNKNOWN7

RECRUITING2

NOT_YET_RECRUITING1

TERMINATED1

Phase mix

NA12

PHASE45

PHASE12

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.